Clinical Trial News and Research

RSS

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine® researchers are leading a new multi-center clinical trial to evaluate a unique surgical method, known as targeted muscle reinnervation (TMR), to treat chronic pain that can result from limb amputation. Around a quarter of all amputees develop chronic pain in the remaining portion of their amputated limb, which can include phantom limb syndrome (pain that is perceived in the portion of the limb that is gone), and prevents many patients from using prostheses.

5 Feb 2015

Battlefield blood transfusion protocol improves patient outcomes

Working to save the lives of military personnel suffering massive blood loss in the Afghanistan and Iraq wars, United States military trauma surgeons developed a blood transfusion protocol that is employed in most military and civilian hospitals today.

5 Feb 2015

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Historic five-year results from the world’s largest clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) were presented last week at the Leipzig Interventional Course, in Germany. The data confirm long-term patency for patients treated with Zilver® PTX®.

From COOK MEDICAL INC. 4 Feb 2015

BioClinica reports 2014 as record year for its eClinical technologies business unit

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that 2014 was a record year for its eClinical technologies business unit, with sales soaring 51 percent above the previous year.

From Clario 4 Feb 2015

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

Sangamo BioSciences, Inc. announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome editing approach, which is designed to provide a one-time lasting therapy for beta-thalassemia, has been accepted by the U.S. Food and Drug Administration and is now active.

4 Feb 2015

New drug gets FDA approval for treatment of women with advanced breast cancer

The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.

4 Feb 2015

EyePromise® eye vitamins offers education guide to promote awareness on AMD

Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.

4 Feb 2015

Movement tracking device can effectively help assess progression of Parkinson's disease

A device that measures movement and balance can effectively help assess and track the progression of Parkinson's disease, even when medications are used to reduce Parkinson's symptoms, UT Southwestern Medical Center research found.

From APDM Wearable Technologies 4 Feb 2015

New Johns Hopkins research suggests that vitamin A may protect children against malaria

Children under age 5 living in sub-Saharan Africa were 54 percent less likely to develop malaria if they had been given a single large dose of vitamin A, new research led by the Johns Hopkins Bloomberg School of Public Health suggests.

4 Feb 2015

ISP shows promise in stopping fatal arrhythmias after heart attack

Case Western Reserve's chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

3 Feb 2015

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Duchenne muscular dystrophy is a congenital disease which causes muscle degeneration and eventual death in teenagers. Recently, researchers from Bern developed an active substance, which they together with an international team tested successfully.

3 Feb 2015

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

3 Feb 2015

Large clinical trial to assess safety, efficacy of two experimental Ebola vaccines opens in Liberia

A large clinical trial to assess the safety and efficacy of two experimental vaccines to prevent Ebola virus infection is now open to volunteers in Liberia. The trial is being led by a recently formed Liberia-U.S. clinical research partnership and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

3 Feb 2015

Study identifies correlations between BioLight's TeaRx diagnostic parameters and benchmark tests for dry eye syndrome

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the completion of a U.S. clinical study, conducted by Ora, Inc. Andover, MA, designed to compare widely used benchmark tests for dry eye with its TeaRx diagnostic parameters that test components of tear film.

3 Feb 2015

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

At the invitation of the White House, The Children's Hospital of Philadelphia (CHOP) sent two special guests to President Barack Obama's announcement today of the Precision Medicine Initiative: Dr. Steven M. Altschuler, CHOP's chief executive officer, and 9-year-old patient Emily Whitehead, now cancer-free thanks to a personalized treatment called T cell therapy, developed at CHOP.

2 Feb 2015

Bionomics initiates BNC210 Phase 1b clinical trial in healthy volunteers

Bionomics Limited has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the Company's drug candidate in development for the treatment of anxiety and depression.

2 Feb 2015

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity.

2 Feb 2015

Study examines why hydroxyurea yields mixed results in children with sickle cell disease

Electronic medication monitoring caps may help physicians put together the puzzle of why children taking a medicine that promises to curb sickle cell disease are showing mixed, confusing results.

2 Feb 2015

Researchers are developing stress-eating smartphone app with NIH support

Researchers at UMass Medical School and Worcester Polytechnic Institute are developing a stress-eating smartphone app that will help users better understand why they overeat, with the support of a $2 million award from the National Institutes of Health.

2 Feb 2015

ABIVAX doses first HIV positive patient in ABX464 Phase IIa clinical trial

ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that enrolment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464.

2 Feb 2015

Clinical Trial News and Research

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Battlefield blood transfusion protocol improves patient outcomes

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

BioClinica reports 2014 as record year for its eClinical technologies business unit

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

New drug gets FDA approval for treatment of women with advanced breast cancer

EyePromise® eye vitamins offers education guide to promote awareness on AMD

Movement tracking device can effectively help assess progression of Parkinson's disease

New Johns Hopkins research suggests that vitamin A may protect children against malaria

ISP shows promise in stopping fatal arrhythmias after heart attack

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Large clinical trial to assess safety, efficacy of two experimental Ebola vaccines opens in Liberia

Study identifies correlations between BioLight's TeaRx diagnostic parameters and benchmark tests for dry eye syndrome

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

Bionomics initiates BNC210 Phase 1b clinical trial in healthy volunteers

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

Study examines why hydroxyurea yields mixed results in children with sickle cell disease

Researchers are developing stress-eating smartphone app with NIH support

ABIVAX doses first HIV positive patient in ABX464 Phase IIa clinical trial

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer